Biotech Blog

Glaukos Poised for Big Things With its iStent

Glaukos (GKOS) manufactures a device called the iStent, which is the first FDA approved Micro-Invasive Glaucoma Surgery (MIGS) device. It is a hollow metal device, very, very small in size, (measuring 1.0 mm long and 0.33 mm wide) that is inserted using a special...

read more

A Post Approval Take on Synergy Pharmaceuticals

Synergy Pharma's (NASDAQ:SGYP) plecanatide approval was supposed to be on January 29, 2017. However, it got approved 10 days early, late in the afternoon of January 19, 2017. Immediately after that, the stock tanked. Investors were hoping to see $8 or more, however,...

read more